On August 12, 2025, NewAmsterdam Pharma Co N.V. entered into a Supply Agreement with A. Menarini International Licensing S.A. to supply obicetrapib products, making them Menarini's exclusive supplier. The pricing will be based on cost of goods sold with adjustments as per the agreement.